|
⚲
|
| Keyboard |
| Miesowicz Frederick
✚
|
|
|---|---|
| CIK # | 0001022855 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001022855] | |
| 4 | [0001022855] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Argos Therapeutics Inc | |
| Miesowicz Frederick |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Argos Therapeutics Inc ARGS
Common Stock
|
2016-01-08 | Grant | 35,554 | $0.00 | |
|
Argos Therapeutics Inc ARGS
Stock Option (right to buy) · derivative
|
2015-06-17 | Grant | 20,000 | $0.00 | |
|
Argos Therapeutics Inc ARGS
Stock Option (right to buy) · derivative
|
2014-07-28 | Grant | 10,200 | $0.00 | |
|
Argos Therapeutics Inc ARGS
Common Stock
|
2014-02-12 | Conversion | 37 | ||
|
Argos Therapeutics Inc ARGS
Series D Preferred Stock · derivative
|
2014-02-12 | Conversion | 619 | $0.00 | |
|
Argos Therapeutics Inc ARGS
Series E Preferred Stock · derivative
|
2014-02-12 | Conversion | 4,941 | $0.00 | |
|
Argos Therapeutics Inc ARGS
Series C Preferred Stock · derivative
|
2014-02-12 | Conversion | 37 | $0.00 | |
|
Argos Therapeutics Inc ARGS
Common Stock
|
2014-02-12 | Conversion | 619 | ||
|
Argos Therapeutics Inc ARGS
Common Stock
|
2014-02-12 | Conversion | 4,941 |